Last reviewed · How we verify

NCT05282927: Group PT

Implementing Group Physical Therapy (PT) for Veterans With Knee Osteoarthritis (Group PT): Function QUERI 2.0

Completed NA Results posted Last updated 10 April 2025
What this trial tests

NA trial testing Implementation Strategy: Foundational REP in Knee Osteoarthritis in 19 participants. Completed in 18 May 2024.

Timeline
21 June 2022
Primary endpoint
18 May 2024
18 May 2024

Quick facts

Lead sponsorVA Office of Research and Development
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposehealth services research
Enrollment19
Start date21 June 2022
Primary completion18 May 2024
Estimated completion18 May 2024
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Eligibility, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Penetration Primary · 7-12 months

Penetration is defined as the average number of patients enrolling in the group physical therapy (PT) program on a monthly basis (defined as completing at least one class).

GroupValue95% CI
Foundational REP1.41± 1.15
Enhanced REP1.13± 0.94
Fidelity Secondary · 7-12 months

Fidelity will be the average number of group PT sessions attended by patients who enroll in the program.

GroupValue95% CI
Foundational REP4.22± 0.90
Enhanced REP5.01± 0.77
Adoption Secondary · 7-12 months

Adoption will be defined as: 1) Delivery of Group PT as a clinical service (delivery of at least 1 Group PT class) by the VA Medical Center, and 2) Enrollment of at least 5 patients.

GroupValue95% CI
Foundational REP6
Enhanced REP6

Sponsor's own description

Implementing Group Physical Therapy (PT) for Veterans with Knee Osteoarthritis (OA): Function QUERI 2.0 (Group PT) aims to implement, evaluate and sustain Group PT in 16 VA sites using a type III effectiveness-implementation hybrid design framework, which will compare implementation strategies while also gathering information about the clinical intervention and related outcomes.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Intensification of Implementation Strategies: Developing a Model of Foundational and Enhanced Implementation Approaches to Support National Adoption and Scale-up.
    Hughes JM, Zullig LL, Choate AL, Decosimo KP, et al · · 2023 · cited 14× · PMID 36029028 · DOI 10.1093/geront/gnac130
  2. Group physical therapy for knee osteoarthritis: protocol for a hybrid type III effectiveness-implementation trial.
    Webb S, Drake C, Coffman CJ, Sullivan C, et al · · 2023 · cited 3× · PMID 37828564 · DOI 10.1186/s43058-023-00502-7
  3. Implementation of Group Physical Therapy for Knee Osteoarthritis: A Cluster Randomized Clinical Trial.
    Allen KD, Webb S, Coffman CJ, Anderson L, et al · · 2025 · cited 1× · PMID 41037266 · DOI 10.1001/jamanetworkopen.2025.35038

Verify or expand the search:

Other trials of Implementation Strategy: Foundational REP

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05282927.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing